| 摘要 |
A pyrimidine derivative of the formula (I): <CHEM> wherein R<1> is a hydrogen atom, alkyl of 1 to 6 carbon atoms, haloalkyl of 1 to 6 carbon atoms, or -NHR<1><1> group; R<2> is a hydrogen or halogen atom, alkyl of 1 to 6 carbon atoms, haloalkyl of 1 to 6 carbon atoms, -(CH2)mC6H5, -NH2, -NHR<1><2>, -NH(CH2)nC6H5, -NH(CH2)pC6H4-OR<1><3>, -N(R<1><4>)(CH2)qC6H5, -NHC(=O)R<1><5>, -NHC(=O)(CH2)rC6H5, -NHC(=O)CH(C6H5)2, -OR<1><6>, or -O(CH2)sC6H5 group; R<3> is -COOH, -COOR<1><7>, hydroxyl, -OR<1><8>, -NH2, -N(R<1><9>)2, -NHR<2><0>, azole, or sulfonic acid group; R<1><1> is alkyl of 1 to 6 carbon atoms or haloalkyl of 1 to 6 carbon atoms; R<1><2>, R<1><3>, R<1><4>, R<1><5>, R<1><6>, R<1><7>, R<1><8>, R<1><9>, and R<2><0> are independently alkyl of 1 to 6 carbon atoms; m is 0 or an integer of 1 to 6; n is 0 or an integer of 1 to 6; p is 0 or an integer of 1 to 6; q is 0 or an integer of 1 to 6; r is 0 or an integer of 1 to 6; and s is 0 or an integer of 1 to 6, or a salt thereof, and a pharmaceutical composition comprising said pyrimidine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier are disclosed. |
